.
  • NIFTY 25,880.45 -80.10 (-0.31%)
  • SENSEX 84,817.28 -285.41 (-0.34%)
 
BSE
NSE

Tuesday, December 09, 2025 , BSE Sensex : 84,817.28 84,817.28(-0.34%) , Adani Ports : 1,492.40 1,492.40(0.85%) , Asian Paints : 2,800.50 2,800.50(-4.28%) , Axis Bank : 1,279.70 1,279.70(0.48%) , Bajaj Finance : 1,020.00 1,020.00(-0.61%) , Bajaj Finserv : 2,071.85 2,071.85(0.63%) , Bharat Electron : 390.60 390.60(1.06%) , Bharti Airtel : 2,086.20 2,086.20(0.01%) , Eternal Ltd : 289.15 289.15(1.37%) , HCL Technologies : 1,670.00 1,670.00(-1.07%) , HDFC Bank : 998.60 998.60(-0.45%) , Hind. Unilever : 2,321.10 2,321.10(0.29%) , ICICI Bank : 1,375.30 1,375.30(-1.01%) , Infosys : 1,597.50 1,597.50(-0.78%) , ITC : 403.50 403.50(0.34%) , Kotak Mah. Bank : 2,124.00 2,124.00(-0.36%) , Larsen & Toubro : 4,010.10 4,010.10(0.36%) , M & M : 3,625.00 3,625.00(-1.52%) , Maruti Suzuki : 16,151.35 16,151.35(-0.19%) , NTPC : 320.00 320.00(0.17%) , Power Grid Corpn : 264.55 264.55(-0.25%) , Reliance Industr : 1,533.15 1,533.15(-0.61%) , SBI : 962.05 962.05(0.62%) , Sun Pharma.Inds. : 1,790.00 1,790.00(-0.30%) , Tata Motors PVeh : 346.15 346.15(-0.56%) , Tata Steel : 161.95 161.95(-0.92%) , TCS : 3,204.90 3,204.90(-1.02%) , Tech Mahindra : 1,565.90 1,565.90(-1.62%) , Titan Company : 3,871.00 3,871.00(2.82%) , Trent : 4,085.20 4,085.20(-0.14%) , UltraTech Cem. : 11,480.00 11,480.00(-0.45%) ,

Nifty 50 : 25,880.45 -80.10(-0.31%) , Adani Enterp. : 2,249.00 32.80(1.48%) , Adani Ports : 1,492.60 12.10(0.82%) , Apollo Hospitals : 7,098.00 2.00(0.03%) , Asian Paints : 2,807.20 -121.10(-4.14%) , Axis Bank : 1,278.60 4.80(0.38%) , Bajaj Auto : 8,975.00 -51.00(-0.57%) , Bajaj Finance : 1,020.20 -6.20(-0.60%) , Bajaj Finserv : 2,073.20 14.00(0.68%) , Bharat Electron : 390.10 3.70(0.96%) , Bharti Airtel : 2,086.50 0.30(0.01%) , Cipla : 1,497.00 -0.60(-0.04%) , Coal India : 379.95 2.60(0.69%) , Dr Reddy's Labs : 1,256.10 -10.40(-0.82%) , Eicher Motors : 7,176.50 34.50(0.48%) , Eternal Ltd : 289.00 3.75(1.31%) , Grasim Inds : 2,770.60 26.40(0.96%) , HCL Technologies : 1,669.10 -19.50(-1.15%) , HDFC Bank : 999.00 -4.10(-0.41%) , HDFC Life Insur. : 758.55 -5.50(-0.72%) , Hind. Unilever : 2,320.50 6.50(0.28%) , Hindalco Inds. : 813.05 -6.40(-0.78%) , ICICI Bank : 1,377.20 -12.40(-0.89%) , Infosys : 1,596.50 -14.30(-0.89%) , Interglobe Aviat : 4,892.50 -31.00(-0.63%) , ITC : 403.90 1.60(0.40%) , Jio Financial : 295.10 -2.10(-0.71%) , JSW Steel : 1,111.80 -7.30(-0.65%) , Kotak Mah. Bank : 2,125.50 -6.10(-0.29%) , Larsen & Toubro : 4,009.90 13.20(0.33%) , M & M : 3,628.20 -53.50(-1.45%) , Maruti Suzuki : 16,154.00 -33.00(-0.20%) , Max Healthcare : 1,068.60 -10.80(-1.00%) , Nestle India : 1,219.40 4.60(0.38%) , NTPC : 320.10 0.60(0.19%) , O N G C : 239.51 0.99(0.42%) , Power Grid Corpn : 264.60 -0.60(-0.23%) , Reliance Industr : 1,534.30 -8.70(-0.56%) , SBI : 960.45 4.05(0.42%) , SBI Life Insuran : 2,000.00 -20.70(-1.02%) , Shriram Finance : 845.30 11.05(1.32%) , Sun Pharma.Inds. : 1,794.80 -1.40(-0.08%) , Tata Consumer : 1,144.90 -0.90(-0.08%) , Tata Motors PVeh : 346.80 -1.50(-0.43%) , Tata Steel : 161.64 -1.83(-1.12%) , TCS : 3,199.30 -37.20(-1.15%) , Tech Mahindra : 1,564.20 -27.60(-1.73%) , Titan Company : 3,851.60 84.60(2.25%) , Trent : 4,083.90 -6.60(-0.16%) , UltraTech Cem. : 11,499.00 -41.00(-0.36%) , Wipro : 258.08 -3.30(-1.26%) , Tuesday, December 09, 2025

Home >> Markets >> Equities >> News - News Details
DAILY MARKET TRACKER
MARKET ANALYSIS
NEWS
CORPORATE INFO
CORPORATE ACTIONS
OTHER MARKETS
Hot Pursuit
03-Dec-2025     15:30
Zim Laboratories gets CDSCO nod for Naproxen'Esomeprazole combination capsule
The formulation has been developed using the company's proprietary drug delivery technologies, combining naproxen delayed-release minitablets and esomeprazole pellets in a single hard gelatin capsule. Zim said the platform offers a differentiated, patient-friendly delivery system and forms part of its New Innovative Product (NIP) pipeline.

The FDC is indicated for adults for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and for reducing the risk of NSAID-associated gastric and duodenal ulcers.

Zim Laboratories stated that the approval strengthens its presence in the pain-management and gastro-protective segments. The company has already signed a commercial supply agreement with an Indian pharmaceutical firm and is working toward launching the product in India in FY 2026'27 (FY27). Zim added that the approval aligns with its strategy of developing innovative, differentiated generics using advanced formulation technologies.

ZIM Laboratories is a research-driven pharmaceutical company that develops, manufactures, and supplies differentiated generic products in oral solid dosage forms across key therapeutic segments.

The company's consolidated net profit dropped 117.6% to Rs 0.42 crore as revenue fell 3.7% to Rs 88.71 crore in the quarter ended September 2025 as compared with the previous quarter ended September 2024.

The scrip rose 0.45% to Rs 71.15 on the BSE.

Powered by Capital Market - Live News